Sandoz Group AG - Registered Shares

NEW
OTCPK:SDZXF (Switzerland)   Registered Shares
$ 89.55 (0%) 10:08 PM EST
42.85
P/B:
4.12
Market Cap:
$ 38.36B
Enterprise V:
$ 42.31B
Volume:
0
Avg Vol (2M):
213.00
Trade In:
Volume:
0
Avg Vol (2M):
213.00

Business Description

Description
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
Name Current Vs Industry Vs History
Cash-To-Debt
0.31
Equity-to-Asset
0.43
Debt-to-Equity
0.61
Debt-to-EBITDA
2.86
Interest Coverage
6.47
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
2.54
Distress
Grey
Safe
Beneish M-Score
-2.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
98.68
9-Day RSI
95.33
14-Day RSI
90.09
3-1 Month Momentum %
3.96
6-1 Month Momentum %
10.17
12-1 Month Momentum %
51.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.18
Quick Ratio
0.77
Cash Ratio
0.25
Days Inventory
187.03
Days Sales Outstanding
79.24
Days Payable
109.5

GF Valueâ„¢

Sandoz Group AG Filings

Filing Date Document Date Form
No Filing Data

Sandoz Group AG Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings conference call for 2026 2026-10-30 09:00 In 126 days
Third quarter earnings results for 2026 2026-10-30 In 125 days
Second quarter earnings results for 2026 2026-08-05 In 39 days
CHF 0.800000 Cash Dividend 2026-04-13 79.41 (+0.00%)
General meeting for 2026 2026-04-09 79.41 (+0.00%)
Jefferies Pan-European Mid-Cap Conference 2026-03-25 79.85 (+0.00%)
BNP Paribas Exane Healthcare Conference 2026-03-24 79.85 (+0.00%)
Bank of America Pharma Bus Tour 2026-03-12 79.90 (+0.00%)
Barclays Global Healthcare Conference 2026-03-10 79.82 (+0.00%)
Guidance call for 2025 2026-03-03 88.00 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:SDZXF

No articles.

Press Release

Subject Date
No Press Release

Articles on Sandoz Group AG

No articles.

Headlines

See More
  • 1
No news.
  • 1